Literature DB >> 15053300

Free radical scavenging, antitumor and anticarcinogenic activity of gossypin.

B H Babu1, H N Jayram, M G Nair, K B Ajaikumar, J Padikkala.   

Abstract

Antioxidant, antitumor and anticarcinogenic activity of gossypin (3,5,8,3',4'-pentahydroxy-7-O glucosyl flavone) was carried out. The compound needed for 50% inhibition of superoxide, hydroxyl and nitric oxide radicals was 3 microg/ml, 41 microg/ml and 12 microg/ml, respectively. Gossypin also impart 50% inhibition at concentrations 37 microg/ml and 43 microg/ml, respectively for in vitro lipid peroxidation. The compound shows IC50 of 30 microM, 42.5 microM and 45.1 microM concentrations in L 929, HT 29 and K 562 cell lines in 72 hrs MTT assay. The compound shows a zone of inhibition of 8 mm in topo I and topo II inhibition assay in Saccharomyces ceriviseae mutant cultures. It reduces the tumor burden in solid tumor harboring animals (p < 0.001) and effectively inhibits the formation of new blood vessels on tumor mass. 20 mg/kg b.wt of gossypin increase the life span of ascites tumor harboring animals (100%) and (164.7%) respectively by oral and intraperitoneal administration of the drug. Gossypin reduced the incidence of papilloma formation and papilloma/mouse in DMBA/ croton oil induced skin papilloma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15053300

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  8 in total

1.  Gossypin inhibits gastric cancer growth by direct targeting of AURKA and RSK2.

Authors:  Li Wang; Xiangyu Wang; Hanyong Chen; Xueyin Zu; Fayang Ma; Kangdong Liu; Ann M Bode; Zigang Dong; Dong Joon Kim
Journal:  Phytother Res       Date:  2018-12-10       Impact factor: 5.878

2.  Gossypin induces G2/M arrest in human malignant glioma U251 cells by the activation of Chk1/Cdc25C pathway.

Authors:  Lei Shi; Jian Chen; Yin-yi Wang; Guan Sun; Jing-ning Liu; Jun-xia Zhang; Wei Yan; Chun-fa Qian; Ning Liu; Zhen Fu; Yong-ping You; Yanjun Zeng
Journal:  Cell Mol Neurobiol       Date:  2011-10-09       Impact factor: 5.046

3.  Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-kappaB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis.

Authors:  Ajaikumar B Kunnumakkara; Asha S Nair; Kwang Seok Ahn; Manoj K Pandey; Zhengfang Yi; Mingyao Liu; Bharat B Aggarwal
Journal:  Blood       Date:  2007-03-01       Impact factor: 22.113

Review 4.  COVID-19, cytokines, inflammation, and spices: How are they related?

Authors:  Ajaikumar B Kunnumakkara; Varsha Rana; Dey Parama; Kishore Banik; Sosmitha Girisa; Sahu Henamayee; Krishan Kumar Thakur; Uma Dutta; Prachi Garodia; Subash C Gupta; Bharat B Aggarwal
Journal:  Life Sci       Date:  2021-02-16       Impact factor: 5.037

Review 5.  Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases.

Authors:  Uzini Devi Daimary; Dey Parama; Varsha Rana; Kishore Banik; Aviral Kumar; Choudhary Harsha; Ajaikumar B Kunnumakkara
Journal:  Curr Res Pharmacol Drug Discov       Date:  2020-12-10

Review 6.  Oroxylin A: A Promising Flavonoid for Prevention and Treatment of Chronic Diseases.

Authors:  Anjana Sajeev; Mangala Hegde; Sosmitha Girisa; Thulasidharan Nair Devanarayanan; Mohammed S Alqahtani; Mohamed Abbas; Samir Kumar Sil; Gautam Sethi; Jen-Tsung Chen; Ajaikumar B Kunnumakkara
Journal:  Biomolecules       Date:  2022-08-26

Review 7.  The promising potential of piperlongumine as an emerging therapeutics for cancer.

Authors:  Dey Parama; Varsha Rana; Sosmitha Girisa; Elika Verma; Uzini Devi Daimary; Krishan Kumar Thakur; Aviral Kumar; Ajaikumar B Kunnumakkara
Journal:  Explor Target Antitumor Ther       Date:  2021-08-30

8.  Comparative evaluation of some flavonoids and tocopherol acetate against the systemic toxicity induced by sulphur mustard.

Authors:  R Vijayaraghavan; Anshoo Gautam; Manoj Sharma; H T Satish; S C Pant; K Ganesan
Journal:  Indian J Pharmacol       Date:  2008-06       Impact factor: 1.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.